RXO (RXO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.06
- EPS estimate
- $0.04
- EPS surprise
- +67.13%
- Revenue surprise
- +8.74%
- Revenue
- $1.8B
- Revenue estimate
- $1.6B
- Reported
- Aug 6, 2026
RXO reported Q2 2026 results on August 6, 2026. Earnings per share were $0.06, ahead of the $0.04 estimate by 67.13%. Revenue was $1.8 billion, above the $1.6 billion consensus. Compared with Q2 2025, EPS rose from $0.04 and revenue rose about 29% from $1.4 billion. The quarter followed two straight losses, of $0.07 per share in Q4 2025 and $0.09 in Q1 2026.
The record in the table is fairly short, starting with Q4 2022. Earnings per share have been small throughout, and the first quarter of each year from 2024 to 2026 was a loss. Annual EPS was $0.30 in 2023 and $0.11 in 2024, then a loss of $0.05 in 2025. Revenue moved the other way. It ran below about $1.0 billion a quarter through Q3 2024, then rose to between $1.4 billion and $1.8 billion from Q4 2024 on. Q2 2026 revenue was the highest in the table. RXO beat the EPS estimate in 12 of 15 quarters.
RXO reported its third quarter between November 6 and November 7 in each of the past three years. That points to early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.04 | $0.06 | +67.13% | $1.8B | SEC |
| Q1 2026 | May 7, 2026 | −$0.10 | −$0.09 | +7.31% | $1.4B | SEC |
| Q4 2025 | Feb 6, 2026 | −$0.04 | −$0.07 | −71.99% | $1.5B | SEC |
| Q3 2025 | Nov 6, 2025 | $0.04 | $0.01 | −72.75% | $1.4B | SEC |
| Q2 2025 | Aug 7, 2025 | $0.03 | $0.04 | +49.81% | $1.4B | SEC |
| Q1 2025 | May 7, 2025 | −$0.02 | −$0.03 | −55.44% | $1.4B | SEC |
| Q4 2024 | Feb 5, 2025 | $0.05 | $0.06 | +11.52% | $1.7B | SEC |
| Q3 2024 | Nov 7, 2024 | $0.05 | $0.05 | +10.38% | $1.0B | SEC |
| Q2 2024 | Aug 7, 2024 | $0.03 | $0.03 | +14.94% | $930.0M | SEC |
| Q1 2024 | May 2, 2024 | −$0.04 | −$0.03 | +21.26% | $913.0M | SEC |
| Q4 2023 | Feb 8, 2024 | $0.04 | $0.06 | +51.52% | $978.0M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.01 | $0.05 | +488.24% | $976.0M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.08 | $0.08 | +1.01% | $963.0M | SEC |
| Q1 2023 | May 3, 2023 | $0.07 | $0.11 | +62.96% | $1.0B | SEC |
| Q4 2022 | Feb 7, 2023 | $0.23 | $0.28 | +20.79% | $1.1B | SEC |
Quarterly revenue
Frequently asked questions
When did RXO (RXO) last report earnings?
RXO last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did RXO beat earnings estimates?
Yes. RXO reported EPS of $0.06 for Q2 2026 against a $0.04 estimate — a 67.13% beat.
How much revenue did RXO report last quarter?
RXO reported $1.8B in revenue for Q2 2026, against a consensus estimate of $1.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.